ArticlePloS one2020

MAGE-A3 is a prognostic biomarker for poor clinical outcome in cutaneous squamous cell carcinoma with perineural invasion via modulation of cell proliferation.

Aaron Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.